Nursing · Independent exam preparation
ACNPC-AG: Acute Care Decisions and Certification Review Study Guide
Practise urgent stabilization, diagnostic discrimination and ethical decisions for AACN's ACNPC-AG exam with 60 focused concepts and 20 explained questions.
By CertMedbry · Updated 27 October 2026
Practise choosing electrical therapy, interpreting respiratory failure, recognizing metabolic emergencies and coordinating care that respects patient goals. Each concept connects a discriminating finding to a clinical or professional decision, followed by an original application and a common error. This selective 60-concept guide addresses both official domains; AACN's complete test plan remains the full scope, including patient care problems, skills, procedures and validated competencies.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification and pathway does this guide cover?
It covers initial ACNPC-AG certification for graduates of adult-gerontology acute care nurse practitioner programs. ACNPC-AG is an advanced practice NP credential; CCRN and PCCN are separate nursing certifications, and ACCNS-AG is a clinical nurse specialist credential. The older adult ACNPC credential became renewal-only with Consensus Model implementation in 2015.
How many questions are there, and how long is the examination?
The July 2026 handbook specifies 175 multiple-choice items and three and a half hours. Of these, 150 items are scored and 25 gather statistical data for future examinations. Plan pacing across the entire examination rather than assuming that an unfamiliar item is unscored.
What delivery modes, item styles and adaptivity are verified?
The handbook describes computer-based testing at PSI testing centers or through live remote proctoring. It also discusses coordinated paper-and-pencil or outside-U.S. arrangements. Multiple-choice items are verified, and the handbook's examples use four options with one answer. The handbook does not establish an adaptive testing algorithm or additional item formats. This guide's questions are independent four-option learning drills.
Which handbook and blueprint dates apply?
The issuer-linked handbook is dated July 2026. Its test plan retains the statement that it applies to examinations taken on and after January 10, 2022. The handbook publication date and the retained test-plan applicability date describe different things; the 2022 date does not establish that the current handbook has been superseded.
How is the official blueprint weighted?
Clinical Judgment is 80%; Professional Caring & Ethical Practice is 20%. Clinical subdivisions are Cardiovascular 15%, Respiratory 11%, Endocrine 5%, Hematology/Immunology/Oncology 6%, Gastrointestinal 3%, Renal/Genitourinary 5%, Integumentary 1%, Musculoskeletal 3%, Neurology 8%, Psychosocial/Behavioral/Cognitive Health 3%, Factors Influencing Health Status 5% and Multisystem 14%. Advocacy/Moral Agency, Caring Practices, Response to Diversity, Collaboration, Systems Thinking and Clinical Inquiry each carry 3%; Facilitation of Learning carries 1%. AACN attributes the subdivision totals below 100% to rounding.
How does this guide apply the blueprint?
The guide contains 48 Clinical Judgment concepts and 12 Professional Caring & Ethical Practice concepts. The questions and flashcards each use a 16-to-four allocation. Concepts include every clinical subdivision and all seven professional competencies, but disease coverage remains selective within those subdivisions. Neither the concept selection nor the small practice samples reproduce every subdivision percentage or the full range of diagnoses, procedures and competencies. Use AACN's complete official outline to plan comprehensive preparation.
What eligibility and jurisdiction distinctions matter?
The standard initial eligibility requirements include current, unencumbered U.S. RN or APRN licensure and qualifying graduate-level adult-gerontology acute care NP education with supervised clinical preparation. The handbook specifies at least 500 supervised clinical practice hours and additional educational requirements. AACN describes its APRN certifications as recognized for licensure in U.S. states and territories; certification does not itself replace a board of nursing's licensure determination or institutional credentialing.
Is there a verified passing percentage or current fee?
The handbook describes a criterion-referenced passing standard established through a modified Angoff process; it does not give a numerical passing score. The issuer page and July 2026 handbook list initial examination fees of $275 for AACN members and $385 for nonmembers, subject to change. Scores on these learning drills do not predict certification results.
How should newer clinical guidance be used alongside the test plan?
The test plan establishes examination scope; clinical references support the clinical recommendations taught here. References include 2026 sepsis and stroke guidance and the 2025 PADIS focused update. AKI staging and emergency renal replacement principles use the published KDIGO 2012 guideline because KDIGO described the 2026 update as a draft being prepared for publication. New guidance should be distinguished from draft recommendations and from the handbook's examination bibliography.
ACNPC-AG Exam Handbook — July 2026 · KDIGO: Acute Kidney Injury and Acute Kidney Disease · KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012 · A Focused Update to SCCM PADIS Guidelines — 2025
This guide addresses AACN Certification Corporation's graduate-level, entry-level Adult-Gerontology Acute Care Nurse Practitioner certification. Clinical decisions concern acutely ill young adults, older adults and frail elderly patients. Acute care scope follows patient acuity across settings. These independently authored learning materials are not official AACN examination items or an endorsed preparation product.
Outline used: ACNPC-AG Exam Handbook, July 2026; included test plan applies to examinations taken on and after January 10, 2022. Verified on October 10, 2026. The workbook label 'Acute Care Nurse Practitioner Certification-Adult-Gerontology (ACNPC-AG)' maps to the handbook's 'Adult-Gerontology Acute Care Nurse Practitioner' examination; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Clinical Judgment80%
1.When does monomorphic ventricular tachycardia require synchronized cardioversion?
A sustained monomorphic ventricular tachycardia with a pulse requires synchronized cardioversion when it causes hypotension, shock, ischemic chest discomfort, acute heart failure or altered mental status. Synchronization times the shock to ventricular depolarization and reduces the risk of delivering energy during vulnerable repolarization. The decisive finding is instability attributable to the rhythm, rather than rate alone. Sedation is appropriate when feasible but must not delay treatment of a deteriorating patient.
Apply it
A patient develops a regular wide-complex tachycardia, blood pressure of 74/42 mm Hg and new confusion while a pulse remains palpable. Prepare synchronized cardioversion and immediate resuscitation support; do not wait for a prolonged antiarrhythmic infusion.
Common pitfall: Choosing an infusion because a pulse is present overlooks unstable perfusion. A pulse distinguishes the pathway, but it does not establish adequate circulation.
2.Why is sustained polymorphic ventricular tachycardia treated with an unsynchronized shock?
Polymorphic ventricular tachycardia has changing QRS morphology, which prevents reliable synchronization to a consistent R wave. Sustained polymorphic ventricular tachycardia therefore requires immediate unsynchronized shock treatment. Once circulation is stabilized, identify the underlying mechanism: prolonged-QT torsades differs from polymorphic tachycardia associated with acute ischemia and a normal QT interval. Magnesium and correction of precipitating factors can address torsades, but these measures do not replace a needed immediate shock.
Apply it
Telemetry shows sustained ventricular tachycardia with continuously changing QRS axes, and the patient loses consciousness. Select unsynchronized shock treatment promptly. After stabilization, review the preceding QT interval, electrolyte results and medication list to guide prevention of recurrence.
Common pitfall: Repeatedly trying to obtain synchronization can delay definitive treatment. Magnesium is not a substitute for electrical treatment of sustained, life-threatening polymorphic ventricular tachycardia.
3.Which cardiac arrest rhythms benefit from defibrillation?
Ventricular fibrillation and pulseless ventricular tachycardia are shockable cardiac arrest rhythms because defibrillation can terminate their disorganized or rapidly reentrant ventricular electrical activity. Asystole and pulseless electrical activity require high-quality CPR, appropriate medication and identification of reversible causes rather than defibrillation. Organized electrical activity does not prove effective mechanical output. Check the patient and rhythm together, minimizing interruptions in compressions while deciding whether a shock is indicated.
Apply it
An unresponsive patient has organized narrow complexes on the monitor but no palpable pulse. Begin the nonshockable arrest pathway while evaluating reversible causes. If the rhythm later changes to ventricular fibrillation, deliver defibrillation and resume compressions promptly.
Common pitfall: Treating every pulseless rhythm with a shock wastes compression time. Electrical organization and mechanical perfusion must be assessed as related but separate findings.
4.How does poor perfusion change the response to bradycardia?
Bradycardia becomes an emergency when the slow rate contributes to hypotension, altered mental status, shock, ischemic discomfort or acute heart failure. Evaluate reversible causes while supporting oxygenation and circulation. If initial medication is ineffective, transcutaneous pacing or an appropriate chronotropic infusion can bridge to definitive management. Confirm mechanical capture during pacing through a pulse or hemodynamic response; pacing spikes and broad complexes alone do not establish effective circulation.
Apply it
A patient with high-grade atrioventricular block becomes diaphoretic and hypotensive despite initial treatment. Prepare pacing while arranging expert support. After pacing starts, verify that each captured complex produces a corresponding pulse and improves blood pressure.
Common pitfall: A low heart rate alone does not mandate emergency pacing. Conversely, apparent electrical capture must not be accepted without checking for a mechanical response.
5.Which findings support intravenous diuresis in acute heart failure?
Hospitalized patients with heart failure and substantial fluid overload should receive prompt intravenous loop diuretic therapy to improve congestion. Elevated venous pressure, edema, pulmonary congestion and weight gain support excess filling pressures, although no single sign should be used alone. Follow symptoms, urine output, weight, electrolytes and renal function to judge response and safety. Persistent congestion requires reassessment of the diuretic strategy rather than assuming the first dose completed treatment.
Apply it
A patient with known heart failure has progressive orthopnea, elevated jugular venous pressure, leg edema and pulmonary congestion while maintaining adequate blood pressure. Begin intravenous loop diuresis and reassess urine output, respiratory symptoms, electrolytes and renal function.
Common pitfall: Giving fluid solely because creatinine is elevated may worsen congestion. Renal results require interpretation alongside perfusion, volume findings and the response to treatment.
6.What are the four foundational medication classes for HFrEF?
Guideline-directed HFrEF treatment includes renin-angiotensin system inhibition, preferably an angiotensin receptor-neprilysin inhibitor when appropriate; an evidence-based beta blocker; a mineralocorticoid receptor antagonist; and an SGLT2 inhibitor. These classes modify disease risk through complementary pathways. Loop diuretics relieve congestion but do not replace the foundational regimen. Selection and initiation require attention to hemodynamic stability, kidney function, potassium, contraindications and the patient's ability to obtain and use treatment.
Apply it
A stable patient with reduced ejection fraction takes a loop diuretic and an evidence-based beta blocker but no other disease-modifying therapy. Review blood pressure, kidney function and potassium, then plan completion of the foundational regimen with follow-up.
Common pitfall: Equating symptomatic improvement after diuresis with complete HFrEF treatment misses persistent disease risk. Medication additions still require individualized assessment of contraindications and tolerance.
New ACC, AHA, HFSA Guideline Updates Recommendations for Managing HF
7.Why does acute aortic syndrome require anti-impulse therapy?
Anti-impulse therapy reduces the force and frequency of left ventricular ejection against the injured aortic wall. Initial intravenous beta blockade is recommended unless contraindicated; additional vasodilation can follow when blood pressure remains excessive. Lowering vascular resistance before controlling heart rate may provoke reflex tachycardia and increase aortic stress. Targets must preserve end-organ perfusion, so the plan depends on blood pressure, heart rate, pain, shock and evidence of malperfusion.
Apply it
A hypertensive patient with a confirmed acute aortic dissection has a heart rate of 118/min and ongoing severe pain. Begin monitored anti-impulse treatment with rate control, then address residual hypertension while the definitive aortic management team is mobilized.
Common pitfall: Starting a vasodilator alone can leave the aorta exposed to reflex tachycardia. Aggressive pressure reduction is also unsafe when it compromises organ perfusion.
2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2
8.When does ascending aortic dissection require immediate surgical involvement?
Acute type A dissection involves the ascending aorta and requires emergency surgical evaluation because rupture, tamponade, coronary compromise and acute aortic regurgitation can develop rapidly. Medical stabilization is a bridge to definitive management. The anatomy of the dissection and the patient's complications determine the operative plan. Renal or limb malperfusion does not make routine observation appropriate; these complications increase urgency and require coordinated evaluation by an experienced aortic team.
Apply it
CT angiography demonstrates an acute ascending aortic dissection in a patient with new renal dysfunction and a cool leg. Arrange immediate aortic surgical management while maintaining monitored stabilization and communicating the evidence of impaired organ perfusion.
Common pitfall: Treating symptom relief after blood pressure control as evidence that surgery can wait ignores the persistent structural threat from an acute ascending aortic dissection.
2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2
9.How can mesenteric malperfusion alter type A dissection management?
Clinically significant mesenteric malperfusion adds threatened bowel viability to the immediate risks of type A dissection. The aortic guideline recognizes either immediate ascending aortic repair or immediate mesenteric revascularization before ascending repair as reasonable approaches in appropriate patients. Imaging evidence of branch involvement must be interpreted alongside abdominal findings, metabolic deterioration and organ dysfunction. The key decision is urgent specialist selection of a reperfusion strategy, rather than an inflexible sequence for every patient.
Apply it
A patient with type A dissection develops severe abdominal pain, worsening acidosis and imaging evidence of impaired mesenteric flow. Escalate immediately to an experienced aortic team to determine whether central repair or mesenteric reperfusion should occur first.
Common pitfall: A universal rule that central repair must always precede mesenteric treatment overlooks the guideline-supported alternative when clinically significant bowel malperfusion threatens irreversible injury.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease — Slide Set
10.Why is ARDS tidal volume based on predicted body weight?
Predicted body weight estimates lung size from height and sex, whereas actual body weight can reflect adipose tissue or fluid accumulation without a proportional increase in lung volume. In ARDS, ventilation using 4–8 mL/kg predicted body weight limits excessive stretch, with approximately 6 mL/kg commonly used initially. The calculation must be combined with assessment of plateau pressure, gas exchange and patient-ventilator interaction. Actual weight can markedly overestimate an appropriate tidal volume in obesity.
Apply it
A patient with ARDS weighs 112 kg, but the documented predicted body weight is 60 kg. An initial target near 6 mL/kg corresponds to 360 mL. Reassess plateau pressure and gas exchange after implementing the setting.
Common pitfall: Using actual weight in a patient with obesity can produce excessive tidal volumes. A correct weight calculation still does not eliminate the need to assess pressure.
ATS/ESICM/SCCM Guideline: Mechanical Ventilation in Adult ARDS
11.What does plateau pressure reveal during ARDS ventilation?
Plateau pressure estimates the pressure applied to the respiratory system when inspiratory flow is paused and the patient is not actively interfering with the measurement. The ARDS guideline recommends limiting plateau pressure to less than 30 cm H2O as part of lung-protective ventilation. A high peak pressure with a lower plateau suggests a resistive contribution, whereas an elevated plateau raises concern about excessive distending pressure or reduced respiratory system compliance.
Apply it
An ARDS patient has a peak pressure of 39 cm H2O and a plateau pressure of 25 cm H2O during a valid inspiratory hold. Investigate airway resistance, secretions and circuit factors rather than treating the peak value as plateau pressure.
Common pitfall: Peak and plateau pressures are not interchangeable. A plateau measurement made during active inspiratory or expiratory effort may not accurately represent passive respiratory mechanics.
ATS/ESICM/SCCM Guideline: Mechanical Ventilation in Adult ARDS
12.How is severe ARDS defined, and when is prolonged prone positioning recommended?
For established ARDS, the Berlin definition classifies severe oxygenation impairment as PaO2/FiO2 at or below 100 mm Hg on invasive ventilation with PEEP at least 5 cm H2O. ARDS also requires onset within one week of a known insult or new or worsening respiratory symptoms, bilateral opacities not fully explained by effusions or collapse, and respiratory failure not fully explained by cardiac failure or fluid overload. The ATS/ESICM/SCCM guideline recommends prone positioning for more than 12 hours daily in severe ARDS. The oxygenation ratio defines severity; the daily hours describe treatment duration.
Apply it
A patient with established ARDS has PaO2 60 mm Hg on FiO2 0.80 and PEEP 10 cm H2O. The ratio is 60/0.80 = 75 mm Hg, meeting the severe category. Arrange prone sessions lasting more than 12 hours daily alongside protective ventilation, airway security, line protection and pressure-injury prevention.
Common pitfall: Use FiO2 as a decimal when calculating the ratio. A low ratio alone does not establish ARDS, and the severity threshold must not be confused with the duration of prone treatment.
ATS/ESICM/SCCM Guideline: Mechanical Ventilation in Adult ARDS
13.Which COPD exacerbations benefit from bilevel noninvasive ventilation?
Bilevel noninvasive ventilation supports inspiration and reduces the work of breathing in acute or acute-on-chronic hypercapnic respiratory failure. The ERS/ATS guideline supports its use in COPD exacerbations with respiratory acidosis, typically pH at or below 7.35, when the patient can be appropriately monitored. Rising carbon dioxide without acidosis does not establish the same indication. Clinical suitability also depends on airway protection, cooperation, secretion burden and immediate access to invasive ventilation when necessary.
Apply it
A cooperative patient with COPD has increased work of breathing, pH 7.28 and PaCO2 68 mm Hg despite initial treatment. Begin a monitored bilevel NIV trial while reassessing respiratory effort, gas exchange and readiness to intubate if deterioration occurs.
Common pitfall: Treating every elevated PaCO2 as acute ventilatory failure ignores compensated chronic hypercapnia. Respiratory acidosis and the patient's clinical trajectory identify the more relevant indication.
Official ERS/ATS Guidelines: Noninvasive Ventilation for Acute Respiratory Failure
14.How should response to a COPD noninvasive ventilation trial be assessed?
An effective NIV trial should produce an early improvement in respiratory distress, respiratory rate or acid-base status. The ERS/ATS guideline emphasizes close monitoring because patients with more severe acidosis have a higher risk of failure. Worsening consciousness, gas exchange, exhaustion or hemodynamics should trigger reassessment for invasive ventilation. A mask in place is not evidence of successful treatment; the relevant endpoint is improved ventilation and clinical stability without an unsafe delay in escalation.
Apply it
After NIV begins, a patient becomes less responsive, respiratory effort weakens and repeat pH falls rather than improves. Treat this as a failing trial, reassess the airway immediately and prepare invasive ventilatory support with the appropriate team.
Common pitfall: Increasing NIV settings repeatedly while the patient deteriorates can postpone necessary intubation. Improvement in oxygen saturation alone does not establish adequate ventilation or airway safety.
Official ERS/ATS Guidelines: Noninvasive Ventilation for Acute Respiratory Failure
15.Why can positive airway pressure help cardiogenic pulmonary edema?
CPAP or bilevel NIV can improve oxygenation and reduce respiratory effort in acute respiratory failure caused by cardiogenic pulmonary edema. Positive pressure recruits flooded or unstable alveoli and influences cardiac loading conditions. The ERS/ATS guideline supports either CPAP or bilevel NIV in suitable patients. This respiratory support accompanies treatment of the cardiac cause and congestion. Shock, impaired airway protection or a need for immediate intubation changes the suitability of a noninvasive approach.
Apply it
An alert patient with acute cardiogenic pulmonary edema is markedly dyspneic and hypoxemic but maintains blood pressure and protects the airway. Apply suitable noninvasive positive pressure while treating congestion and reassessing oxygenation, work of breathing and hemodynamics.
Common pitfall: Applying positive pressure without reassessing blood pressure can miss worsening circulation. Noninvasive support does not correct every cause of pulmonary edema or replace cardiac treatment.
Official ERS/ATS Guidelines: Noninvasive Ventilation for Acute Respiratory Failure
16.When is airway protection more important than avoiding intubation?
NIV requires a patient who can maintain a sufficiently safe airway and tolerate the interface. Active vomiting, inability to clear secretions, profound deterioration in consciousness or an immediate need for invasive support can make a mask-based strategy unsafe. The mechanism is straightforward: pressure support does not secure the trachea or reliably prevent aspiration. Assess airway protection separately from oxygen saturation because a temporarily acceptable saturation can coexist with an unsafe airway.
Apply it
A patient receiving NIV develops repeated vomiting and cannot manage oral secretions as consciousness declines. Remove the assumption that a good saturation makes NIV safe; obtain urgent airway assistance and prepare definitive airway management while supporting oxygenation.
Common pitfall: Focusing exclusively on saturation can obscure aspiration risk and loss of airway protection. NIV should not become a reason to delay an otherwise necessary airway intervention.
Official ERS/ATS Guidelines: Noninvasive Ventilation for Acute Respiratory Failure
17.How can diabetic ketoacidosis occur without marked hyperglycemia?
DKA reflects insufficient insulin activity with ketone production and metabolic acidosis; marked hyperglycemia is not essential. The 2024 consensus recognizes euglycemic DKA, including presentations associated with SGLT2 inhibitors, reduced intake or other relevant circumstances. In a patient with diabetes, substantial ketonemia and acidosis should prompt DKA evaluation even when glucose is below 200 mg/dL. Blood beta-hydroxybutyrate directly assesses the predominant ketone and is more useful than glucose alone for recognizing the crisis.
Apply it
A patient taking an SGLT2 inhibitor develops vomiting and deep respirations after poor intake. Glucose is 174 mg/dL, beta-hydroxybutyrate is 5.1 mmol/L and pH is 7.23. Recognize a ketoacidotic emergency despite the modest glucose concentration.
Common pitfall: Excluding DKA because glucose is below a familiar hyperglycemic threshold can delay treatment. Urine ketones also do not directly quantify the predominant circulating ketone.
Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report — 2024
18.Why must potassium influence the timing of insulin in DKA?
Patients with DKA can have substantial total-body potassium depletion even when their initial serum potassium is normal or elevated. Insulin moves potassium into cells, and correction of acidosis can further lower the measured concentration. The 2024 consensus advises potassium replacement and postponement of insulin when potassium is below 3.5 mmol/L until it rises above that level. Kidney function, urine output and serial measurements guide safe replacement and subsequent insulin treatment.
Apply it
A patient with confirmed DKA has potassium of 3.2 mmol/L and ongoing urinary losses. Begin appropriate potassium replacement and monitoring before insulin, then initiate insulin once potassium is safely corrected according to the treatment protocol.
Common pitfall: Starting insulin immediately because acidosis is severe can worsen dangerous hypokalemia. A single acceptable potassium result also does not remove the need for continued monitoring.
Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report — 2024
19.How does HHS differ from DKA, and why must osmolality guide treatment?
The 2024 consensus defines HHS by glucose at least 600 mg/dL, effective serum osmolality above 300 mOsm/kg or total osmolality above 320 mOsm/kg, beta-hydroxybutyrate below 3 mmol/L, and absence of significant acidosis: pH at least 7.3 and bicarbonate at least 15 mmol/L. Effective osmolality is calculated as 2 × sodium plus glucose/18 when glucose is in mg/dL. Severe osmotic diuresis produces dehydration and hypertonicity without the degree of ketogenesis typical of DKA. Treatment must follow volume status, potassium and osmolality; the recommended osmolality decline is 3–8 mOsm/kg/hour.
Apply it
A dehydrated patient has glucose 720 mg/dL, sodium 148 mmol/L, beta-hydroxybutyrate 1.0 mmol/L, pH 7.36 and bicarbonate 22 mmol/L. Effective osmolality is 296 + 40 = 336 mOsm/kg, supporting HHS. Monitor the rate of osmotic correction during treatment rather than following glucose alone.
Common pitfall: Altered consciousness is not required for the diagnosis. Significant ketonemia or acidosis suggests a mixed DKA/HHS presentation and changes the treatment assessment.
Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report — 2024
20.How is the 4Ts score calculated, and what treatment is needed while HIT testing proceeds?
Use the scoring table in the December 2018 ASH HIT pocket guide, assigning 0–2 points to each component. Thrombocytopenia: 2 points for a platelet fall greater than 50% with nadir at least 20 × 10^9/L; 1 for a fall of 30–50% or nadir of 10–19 × 10^9/L; 0 for a fall below 30% or nadir below 10 × 10^9/L. Timing: 2 points for clear onset on days 5–14, or a fall within one day with heparin exposure within the previous 30 days. Assign 1 for timing compatible with days 5–14 but uncertain because of missing information, onset after day 14, or a fall within one day with exposure more than 30 through 100 days earlier. Assign 0 for a fall within four days without recent exposure; this explicitly includes day 4. Thrombosis or other sequelae: 2 points for new confirmed thrombosis, injection-site skin necrosis, an anaphylactoid reaction after an intravenous heparin bolus, or adrenal hemorrhage; 1 for progressive or recurrent thrombosis, non-necrotizing erythematous skin lesions, or suspected unconfirmed thrombosis; 0 for none. Other causes: 2 points if none are apparent, 1 if possible, and 0 if definite. Totals of 0–3 indicate low probability, 4–5 intermediate probability, and 6–8 high probability. Intermediate or high probability warrants stopping heparin and obtaining an immunoassay. High probability requires empiric therapeutic-intensity non-heparin anticoagulation. For intermediate probability without another therapeutic indication, use prophylactic intensity when bleeding risk is high and therapeutic intensity otherwise. Another therapeutic anticoagulation indication favors therapeutic intensity.
Apply it
Platelets fall from 240 to 96 × 10^9/L beginning on day 7, a new proximal DVT is confirmed, and no alternative cause is apparent: 2 + 2 + 2 + 2 = 8. Stop all heparin and begin therapeutic-intensity non-heparin anticoagulation while testing proceeds. Without thrombosis and with a possible competing cause, the score is 5. If that same decline instead clearly begins on day 4 without recent heparin exposure, timing receives zero points and the latter total becomes 3.
Common pitfall: A normal-range platelet count can conceal a substantial percentage decline. Obtain the exposure history and platelet trend before assigning timing points. Missing information can produce a falsely low score; reassess and recalculate when new information appears. A reliable low-probability score generally argues against HIT testing and empiric HIT treatment.
ASH: Diagnosis and Management of Heparin-Induced Thrombocytopenia · watermark-ash_vte_hit_pocketguide.pdf
21.Why does acute HIT require non-heparin anticoagulation, and when can warfarin be started?
Immune HIT activates platelets and generates thrombin, producing a high risk of thrombosis despite thrombocytopenia. Stop every heparin source, including flushes, and use an appropriate non-heparin anticoagulant selected for clinical stability, bleeding risk, organ function and procedural needs. Low-molecular-weight heparin is unsuitable because it remains a heparin product. Do not initiate warfarin before platelet recovery, usually to at least 150 × 10^9/L: its early reduction of natural anticoagulant proteins can worsen thrombosis. If warfarin has already been started in acute HIT, discontinue it and administer vitamin K while providing appropriate non-heparin anticoagulation.
Apply it
A patient with confirmed HIT, a proximal DVT and platelets of 58 × 10^9/L has a new warfarin order. Stop all heparin, provide suitable non-heparin anticoagulation and defer warfarin until platelet recovery rather than using it as an immediate substitute.
Common pitfall: Stopping heparin alone leaves the prothrombotic process untreated. A low platelet count does not protect against thrombosis, and discharge convenience does not justify premature warfarin.
ASH: Diagnosis and Management of Heparin-Induced Thrombocytopenia
22.Which electrolyte pattern suggests tumor lysis syndrome?
Rapid breakdown of malignant cells releases intracellular potassium, phosphate and nucleic acids. Nucleic-acid metabolism increases uric acid, while released phosphate binds calcium and can promote calcium-phosphate precipitation, producing secondary hypocalcemia. The characteristic pattern is hyperkalemia, hyperphosphatemia, hyperuricemia and hypocalcemia, often accompanied by acute kidney injury. Reduced renal clearance further increases the solute burden. Tumor lysis can follow cancer treatment or occur spontaneously. The MD Anderson adult TLS algorithm supports close electrolyte and renal monitoring, hydration tailored to clinical status, uric-acid management and urgent treatment of associated electrolyte emergencies.
Apply it
After treatment for a high-burden hematologic malignancy, a patient develops oliguria, rising creatinine, potassium of 6.6 mmol/L with ECG changes, elevated phosphate and uric acid, and low calcium. Recognize tumor lysis and immediately address the hyperkalemic cardiac risk while arranging oncology and nephrology management. The MD Anderson algorithm includes intravenous calcium for hyperkalemic ECG changes, insulin with glucose management to shift potassium intracellularly, and dialysis when required for severe complications.
Common pitfall: Avoid automatically replacing calcium solely because its concentration is low. In asymptomatic hypocalcemia with hyperphosphatemia, calcium replacement can increase calcium-phosphate precipitation; the MD Anderson algorithm recommends withholding routine replacement until phosphate normalizes. Symptomatic hypocalcemia and hyperkalemic ECG changes require a different response. Routine urine alkalinization is not recommended for TLS prevention or treatment. Absence of recent chemotherapy does not exclude spontaneous tumor lysis.
ACNPC-AG Exam Handbook — July 2026 · KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012 · clin-management-tumor-lysis-web-algorithm.pdf
23.Why can fever with neutropenia require urgent treatment despite subtle skin findings?
Neutropenia weakens the inflammatory response, so serious skin or soft tissue infection may produce little erythema, tenderness or purulence. The fever-definition section of the SCCM/IDSA guidance identifies fever during chemotherapy-associated neutropenia as a single oral temperature of at least 38.3°C or an oral temperature greater than 38.0°C sustained for at least one hour. Neutropenia generally means an absolute neutrophil count below 500 cells/µL or expected to fall below that level within 48 hours. Febrile neutropenia requires urgent assessment and prompt empiric antibacterial treatment. When an initial skin or soft tissue focus is identified, the IDSA skin-infection guideline recommends hospitalization and vancomycin plus an antipseudomonal agent such as cefepime, piperacillin-tazobactam or a carbapenem.
Apply it
A patient receiving myelosuppressive chemotherapy has a single oral temperature of exactly 38.3°C, an absolute neutrophil count of 180 cells/µL and a small new skin lesion. The single-temperature fever criterion is met. Arrange urgent inpatient evaluation, obtain appropriate cultures and lesion sampling without delaying empiric treatment, and use the skin-focus regimen rather than waiting for a second fever measurement or prominent redness and pus.
Common pitfall: Subtle local inflammation does not establish a mild infection in a neutropenic patient. Vancomycin-containing combination therapy here addresses an identified skin or soft tissue focus; vancomycin is not a routine requirement for every febrile-neutropenia presentation. The SCCM/IDSA fever document directly states the temperature definition, but its general ICU evaluation recommendations do not specifically cover patients with severe immunocompromise.
IDSA Guidelines: Skin and Soft Tissue Infections · SCCM/IDSA Guidelines for Evaluating New Fever in Adult Patients in the ICU
24.When is CT useful in acute pancreatitis?
Acute pancreatitis can often be diagnosed from characteristic abdominal pain and pancreatic enzyme elevation without immediate CT. The 2024 ACG highlights reserve CT for diagnostic uncertainty or failure to improve after approximately 48–72 hours. Imaging should answer a management question, such as whether another diagnosis or a complication explains the course. Routine early CT solely to establish severity can add exposure without changing initial management, particularly when the diagnosis is already secure.
Apply it
A patient has characteristic epigastric pain, lipase more than three times the upper reference limit and an improving uncomplicated course. Avoid automatic immediate CT. Reconsider cross-sectional imaging if the diagnosis becomes uncertain or improvement fails over the expected interval.
Common pitfall: Ordering CT for every enzyme-confirmed presentation confuses diagnostic certainty with the need for imaging. New deterioration or persistent uncertainty changes that decision boundary.
25.Which findings make gastrointestinal hemorrhage an immediate resuscitation problem?
Hematemesis or melena accompanied by hypotension, tachycardia, syncope, confusion or poor peripheral perfusion suggests clinically important blood loss. Hematochezia can also occur with brisk upper gastrointestinal bleeding. Assess airway safety, circulation and ongoing loss together; active hematemesis with declining consciousness threatens aspiration as well as perfusion. Establish vascular access, obtain blood counts, coagulation studies and compatibility testing, and initiate resuscitation while arranging bleeding control. The 2019 International Consensus Group guideline explains that hemoglobin can initially remain unchanged during acute blood loss. Whole blood is lost before plasma redistribution or administered fluids reveal the decline in hemoglobin concentration.
Apply it
A patient has repeated hematemesis, blood pressure of 82/48 mm Hg, pulse of 124/min and increasing drowsiness, but an initial hemoglobin of 12.1 g/dL. These findings require immediate airway and circulatory assessment, resuscitation and urgent gastrointestinal evaluation. Prepare and administer blood-product support according to the severity of ongoing hemorrhage and clinical status. The consensus guideline explicitly excludes exsanguinating bleeding from reliance on a numeric hemoglobin transfusion threshold; anticipated further decline and the patient's condition matter.
Common pitfall: A single preserved hemoglobin value cannot establish safety during active bleeding. Repeated measurements help assess the course, but resuscitation must proceed when shock is evident. Transfusion thresholds used in patients without exsanguinating hemorrhage should not delay blood support in a patient with massive ongoing loss. Stool color can suggest a source, but the perfusion deficit determines immediate urgency.
ACNPC-AG Exam Handbook — July 2026 · CAG-CPG-Nonvariceal-UGIB-Annals-Dec2019.pdf
26.How do creatinine and urine output establish AKI?
The published KDIGO 2012 criteria identify AKI through a creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/hour for six hours. Creatinine and urine output provide complementary evidence; either can establish AKI. Interpret trends against a credible baseline and the clinical timeline. A value still within a laboratory reference range can represent a meaningful acute rise.
Apply it
A patient's creatinine rises from 0.8 to 1.2 mg/dL within 36 hours. Recognize that the 0.4 mg/dL increase meets the creatinine criterion for AKI, then investigate perfusion, medications, obstruction and other relevant causes.
Common pitfall: Waiting for creatinine to exceed the laboratory reference range can miss AKI. A change from baseline and its timing are more informative than the flagged result alone.
KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
27.Which AKI complications require emergency renal replacement therapy?
KDIGO 2012 recommends emergency renal replacement therapy when life-threatening abnormalities of fluid, electrolytes or acid-base balance are present. Examples include refractory hyperkalemia, severe treatment-resistant acidosis and pulmonary edema that cannot be adequately managed medically. The need is driven by the complication and its response to treatment, rather than a single creatinine threshold. Immediate stabilization and nephrology or critical care coordination proceed together when an urgent indication threatens cardiac, respiratory or other organ function.
Apply it
A patient with oliguric AKI has worsening pulmonary edema and dangerous hyperkalemia despite appropriate temporizing and medical measures. Arrange emergency renal replacement therapy while continuing immediate stabilization, rather than waiting for another creatinine measurement to cross a chosen threshold.
Common pitfall: Delaying therapy until creatinine reaches an arbitrary number ignores life-threatening physiology. Temporizing potassium treatment does not necessarily provide sustained potassium removal in persistent kidney failure.
KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
28.How can persistent acidosis after DKA treatment be distinguished from ongoing ketoacidosis?
During DKA recovery, chloride-rich fluid administration and urinary loss of ketoanions can produce a hyperchloremic metabolic acidosis with a normal anion gap. Calculate the anion gap as sodium minus the sum of chloride and bicarbonate, but assess ketones directly rather than using the gap as the sole resolution criterion. The 2024 consensus defines DKA resolution as ketones below 0.6 mmol/L with venous pH at least 7.3 or bicarbonate at least 18 mmol/L; glucose should ideally be below 200 mg/dL. Low bicarbonate alone can therefore persist after ketogenesis has resolved.
Apply it
After treatment, sodium is 140 mmol/L, chloride 114 mmol/L, bicarbonate 16 mmol/L, beta-hydroxybutyrate 0.4 mmol/L and venous pH 7.32. The gap is 140 − 130 = 10 mmol/L. Cleared ketones and pH meeting the resolution criterion support recovery from DKA with residual hyperchloremic acidosis rather than persistent ketoacidosis.
Common pitfall: Do not prolong DKA treatment solely because bicarbonate remains low. Conversely, normalized glucose does not establish resolution when ketones and acidosis persist.
Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report — 2024
29.Which skin findings should trigger concern for necrotizing infection?
Severe pain disproportionate to visible skin changes, rapidly progressive swelling, systemic toxicity, bullae, skin necrosis or crepitus should raise concern for a necrotizing soft tissue infection. Deep tissue involvement may initially exceed the superficial appearance. IDSA recommends prompt surgical consultation when an aggressive infection with systemic toxicity or suspected necrotizing fasciitis is present. Antimicrobial treatment and resuscitation are important, but source control requires urgent surgical assessment rather than waiting for characteristic late skin findings.
Apply it
A patient with diabetes has rapidly escalating thigh pain, fever and hypotension despite only modest erythema. Request urgent surgical evaluation for possible necrotizing infection while initiating appropriate resuscitation and antimicrobial management; do not require crepitus before escalating.
Common pitfall: Labeling disproportionate pain as uncomplicated cellulitis can delay source control. Absence of gas or dramatic skin necrosis does not safely exclude an early deep infection.
30.What makes a low-energy fracture a bone-health warning?
A fragility fracture occurs after trauma that would not ordinarily fracture healthy bone, often a fall from standing height or less. It signals possible skeletal weakness and increased risk of another fracture, rather than being explained completely by the fall itself. AAOS emphasizes subsequent bone-health evaluation. Acute fracture management should therefore connect to assessment of osteoporosis, relevant contributors and future fracture prevention. The mechanism of injury helps distinguish a fragility event from higher-energy trauma.
Apply it
An older adult sustains a distal radius fracture after tripping while walking indoors. Alongside fracture treatment, identify the standing-height mechanism as a fragility warning and arrange bone-health evaluation and a plan to reduce subsequent fracture risk.
Common pitfall: Describing the event only as an accidental fall misses the skeletal warning. A single low-energy fracture can justify evaluation even without a previous osteoporosis diagnosis.
31.How should function influence discharge planning after a fracture?
A technically completed fracture treatment does not establish that a patient can function safely at home. The ACNPC-AG competencies require evaluation of therapy effects, geriatric syndromes, resources and the need for assistance or monitoring. Compare current transfers, mobility and self-care with baseline, then match the care environment to actual needs. Pain, cognition, living arrangements and caregiver capacity can interact, making discharge safety a functional decision rather than a radiographic judgment alone.
Apply it
After fracture treatment, a patient is medically stable but cannot transfer without two-person assistance and lives alone. Assess rehabilitation and support needs before selecting the discharge setting, involving therapy staff and the patient in a realistic transition plan.
Common pitfall: Equating stable imaging with discharge readiness ignores functional dependence. A proposed caregiver should not be assumed able to provide complex assistance without assessing actual capacity.
32.Why can a low stroke severity score still represent a disabling deficit?
A numerical stroke score summarizes selected deficits but does not fully describe their impact on a patient's daily function. Aphasia, visual loss or weakness affecting essential activities can be disabling despite a low total score. The 2026 AHA/ASA summary emphasizes treatment decisions based on disabling symptoms, not a low score alone. Assess what the patient cannot now do, then integrate onset timing, imaging and contraindications into reperfusion assessment. For appropriately selected non-disabling ischemic stroke, the guidance favors dual antiplatelet therapy over routine intravenous thrombolysis after hemorrhage has been excluded.
Apply it
One patient has a low stroke score but aphasia preventing meaningful communication; continue urgent reperfusion assessment. Another has isolated mild tingling with preserved strength, language, gait and usual activities; assess the non-disabling antiplatelet pathway after imaging and evaluation of contraindications.
Common pitfall: Mild score and non-disabling symptoms are not interchangeable. The functional consequences of the specific deficit determine which treatment distinction applies.
AHA/ASA: Top Take-Home Messages for the Emergency Physician — 2026 Stroke Guideline
33.What does a lucid interval followed by deterioration and a fixed pupil suggest after head trauma?
Transient recovery after traumatic loss of consciousness followed by rapid neurologic deterioration should raise concern for an expanding intracranial hematoma. A new unilateral dilated, unreactive pupil adds concern for mass effect and third-nerve compression. An epidural hematoma is a classic explanation for this pattern, although the pattern is not present in every case and does not replace imaging. Treat the evolving consciousness and pupil changes as an intracranial emergency requiring immediate stabilization, urgent head imaging and neurosurgical involvement.
Apply it
After a fall, a patient initially loses consciousness, becomes conversant and then rapidly becomes less responsive with a new fixed dilated left pupil. Suspect an expanding epidural hematoma with dangerous mass effect; support airway and circulation while arranging emergency imaging and neurosurgical assessment.
Common pitfall: An initially lucid examination does not exclude a dangerous intracranial bleed. Do not wait for a complete late herniation syndrome before responding to deterioration.
34.Which thrombolytic agents and treatment windows are recognized in current stroke guidance?
The 2026 AHA/ASA emergency-physician summary endorses either alteplase or tenecteplase for eligible patients within 4.5 hours of symptom onset or last known well. A disabling deficit can warrant thrombolysis assessment despite a low stroke score. Brain imaging must exclude hemorrhage, and blood pressure, bleeding risks and other contraindications must be assessed. Selected patients with unknown onset or presentation 4.5–9 hours after onset may qualify for extended-window treatment using advanced imaging selection, such as MRI diffusion–FLAIR mismatch or perfusion mismatch. Extended-window eligibility is not established by a normal noncontrast CT alone.
Apply it
A patient arrives two hours after witnessed onset of disabling aphasia. Noncontrast CT shows no hemorrhage, blood pressure meets the treatment threshold and no contraindication is identified. Either alteplase or tenecteplase is a supported choice. A patient awakening with the same deficit requires an imaging-based selection assessment rather than assignment of the same conventional onset interval.
Common pitfall: Do not omit the treatment window when remembering agent choices. Excluding hemorrhage is necessary, but selected extended-window treatment also requires the relevant advanced imaging criteria.
AHA/ASA: Top Take-Home Messages for the Emergency Physician — 2026 Stroke Guideline
35.Why should thrombectomy eligibility be assessed separately from thrombolysis eligibility?
Intravenous thrombolysis and endovascular thrombectomy have distinct eligibility criteria, so ineligibility for intravenous treatment does not automatically eliminate endovascular treatment. Vessel location, elapsed time, baseline function, neurologic severity and imaging findings determine the applicable thrombectomy pathway. One defined 2026 AHA/ASA recommendation is thrombectomy within 24 hours of symptom onset for basilar artery occlusion when baseline modified Rankin Scale score is 0–1, presenting NIHSS score is at least 10, and posterior-circulation ASPECTS is at least 6. This combination identifies a specified posterior-circulation treatment pathway with limited ischemic damage.
Apply it
An adult with a confirmed basilar artery occlusion presents 18 hours after symptom onset. Baseline modified Rankin Scale score is 1, presenting NIHSS score is 14, and posterior-circulation ASPECTS is 8. Although the patient has been determined ineligible for intravenous thrombolysis, these findings meet the stated basilar-occlusion thrombectomy criteria. Activate the thrombectomy pathway and arrange immediate treatment or transfer to a capable center; thrombolysis ineligibility should not end reperfusion assessment.
Common pitfall: The basilar-artery criteria are one specified pathway, not a universal rule for every intracranial occlusion. Anterior-circulation pathways have their own vessel, imaging, time and clinical criteria. A patient outside the stated basilar thresholds does not meet this particular recommendation; those thresholds alone do not establish eligibility or ineligibility under every other pathway.
AHA/ASA: Top Take-Home Messages for the Emergency Physician — 2026 Stroke Guideline · 2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-stroke-a-guideline-from.pdf
36.Why is intensive glucose normalization avoided after ischemic stroke?
Persistent hyperglycemia during acute ischemic stroke warrants treatment, but intensive normalization increases severe hypoglycemia without improving functional outcomes. Section 4.5 of the 2026 AHA/ASA guideline states that treating persistent hyperglycemia toward 140–180 mg/dL with close monitoring is reasonable. Glucose below 60 mg/dL requires treatment. Intravenous insulin targeting 80–130 mg/dL is not recommended to improve three-month functional outcomes. These distinctions support management of hyperglycemia while limiting treatment-related hypoglycemia, which can injure the brain and complicate interpretation of a changing neurologic examination.
Apply it
An acute ischemic stroke patient has repeated glucose measurements of 218 and 224 mg/dL. A proposed insulin protocol targets 85–100 mg/dL. Replace that intensive target with monitored treatment toward 140–180 mg/dL, adjusting therapy to avoid hypoglycemia. If neurologic function worsens and glucose measures 54 mg/dL, promptly treat the hypoglycemia and reassess the neurologic findings while continuing evaluation for other causes of deterioration.
Common pitfall: A normal fasting laboratory range is not automatically the safest acute treatment target. Avoiding intensive normalization does not justify leaving persistent hyperglycemia untreated. Repeated glucose monitoring is essential because insulin requirements can change during acute illness and treatment. A glucose check during neurologic deterioration can identify a reversible contributor, but does not replace assessment for recurrent ischemia, hemorrhage or other complications.
AHA/ASA: Top Take-Home Messages for the Emergency Physician — 2026 Stroke Guideline · 2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-stroke-a-guideline-from.pdf
37.How does delirium differ from a stable baseline cognitive disorder?
Delirium is characterized by an acute or fluctuating disturbance in attention and cognition, often developing during illness or exposure to precipitating factors. A preexisting cognitive disorder can increase vulnerability but does not explain every new change. SCCM recommends regular assessment with validated tools in critically ill adults. Compare the examination with baseline, assess arousal and attention, and investigate contributors such as medication effects, infection, physiologic disturbance, sleep disruption or sensory deprivation.
Apply it
A patient with mild baseline dementia becomes intermittently inattentive and disoriented overnight, then appears clearer during morning rounds. Use a validated delirium assessment and investigate the acute change rather than attributing the fluctuating behavior entirely to dementia.
Common pitfall: Quiet withdrawal can be delirium even without agitation. A single lucid conversation does not exclude a syndrome whose defining feature can include fluctuation over time.
38.Which interventions form the foundation of ICU delirium care?
Delirium care emphasizes identification of reversible contributors and multicomponent support, including orientation, sleep promotion, mobility and access to hearing or visual aids. These interventions address the environmental and physiologic disruptions that sustain cognitive dysfunction. The 2025 PADIS focused update could not recommend for or against antipsychotics for treating delirium because of insufficient evidence. An antipsychotic should therefore not be presented as a proven routine treatment that replaces assessment and supportive care.
Apply it
An older ICU patient develops delirium after several nights of poor sleep without access to hearing aids. Review medications and acute illness contributors, restore sensory aids, support orientation and sleep, and mobilize safely rather than reflexively prescribing scheduled antipsychotics.
Common pitfall: Suppressing visible agitation does not necessarily resolve delirium. Medication for a specific immediate safety problem should not be confused with a proven treatment for the syndrome.
SCCM PADIS Guidelines — 2018 · A Focused Update to SCCM PADIS Guidelines — 2025
39.How should frailty and mobility shape recovery planning?
Recovery planning should consider baseline function, physiologic reserve and current assistance needs rather than chronological age alone. The ICU Liberation framework includes early mobility and exercise because prolonged immobility contributes to weakness and loss of independence. Activity must be matched to current respiratory, hemodynamic and neurologic safety. Compare what the patient could do before illness with present performance, then build a coordinated plan that supports recovery without assuming either universal bed rest or unrestricted activity.
Apply it
An older patient who previously walked independently now needs help sitting after an ICU stay. Assess current stability and collaborate with rehabilitation staff on graded activity, documenting functional goals and the assistance needed for safe progression.
Common pitfall: Using age alone to deny rehabilitation overlooks individual reserve. Conversely, a mobility goal should not override active instability or the need for appropriate staff and equipment.
SCCM ICU Liberation Bundle · ACNPC-AG Exam Handbook — July 2026
40.Why should apparent nonadherence prompt an access assessment?
A prescribed plan works only if the patient can obtain, understand and carry it out. The ACNPC-AG test plan includes social determinants, health literacy, access and medical nonadherence as factors influencing health status. Distinguish inability from an informed preference by asking about cost, transportation, housing, cognition, regimen complexity and support. This assessment identifies modifiable barriers and helps create a feasible plan instead of treating every missed dose as evidence of unwillingness.
Apply it
A patient repeatedly misses diuretic doses because the shared bathroom is inaccessible and transportation to the pharmacy is unreliable. Address those barriers with the patient and care team, then adapt the plan and confirm that it can be followed.
Common pitfall: Repeating instructions without investigating the obstacle can leave the same failure mechanism in place. A documented prescription is not evidence that the patient has usable access.
41.How do goals of care guide treatment during serious illness?
Goals-of-care assessment links treatment choices to the patient's priorities, acceptable burdens and desired outcomes. The ACNPC-AG competencies include palliative care, symptom management and care over time, including terminal illness. Clarify what the patient understands, what outcomes matter and how available interventions fit those aims. Palliative support can accompany disease-directed treatment. A decision about one intervention should be interpreted specifically rather than assumed to determine every other treatment or symptom-relief measure.
Apply it
A patient with advanced heart failure wants relief of breathlessness and time at home but fears repeated invasive procedures. Discuss expected benefits and burdens of options, integrate palliative support and document a plan consistent with those priorities.
Common pitfall: Assuming that palliative care requires stopping all disease-directed treatment creates a false choice. Specific preferences should guide decisions rather than broad labels about treatment intensity.
42.Why is source control essential in sepsis, and how urgently should it occur?
Antimicrobials may not eliminate infection when an undrained collection, infected device or obstructed infected system continues to sustain it. The 2026 Surviving Sepsis Campaign conditionally favors early source control, ideally within six hours of diagnosis when an intervention is required. This is a very-low-certainty recommendation, not an inflexible deadline for every procedure. Identify the required intervention promptly and coordinate resuscitation, antimicrobials and source control in parallel, weighing procedural feasibility and risk against ongoing uncontrolled infection.
Apply it
A septic patient remains unstable despite antimicrobials, and imaging reveals an obstructed infected collecting system. Mobilize urgent specialist decompression, aiming for intervention within six hours of diagnosis when feasible while continuing stabilization. Do not postpone procedural planning until blood pressure and laboratory values have completely normalized.
Common pitfall: Changing antibiotics alone does not relieve an obstruction. The six-hour ideal supports early action but does not remove the need to individualize the procedure and its timing.
Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
43.How do dynamic measures improve fluid decisions in septic shock?
Fluid responsiveness asks whether an increase in preload produces a meaningful increase in stroke volume or cardiac output. Dynamic assessment, such as passive leg raising with a real-time flow measurement, is more informative than an isolated static filling pressure for deciding whether additional fluid may help. The 2026 sepsis guidance supports dynamic measures. Responsiveness does not automatically equal a need for fluid: perfusion deficit, pulmonary tolerance and the overall trajectory still determine whether a bolus is beneficial.
Apply it
After initial resuscitation, a septic patient remains hypotensive and develops pulmonary congestion. A properly performed passive leg raise produces no meaningful increase in measured stroke volume. Reassess vasopressor support and other causes rather than giving repeated unselected fluid boluses.
Common pitfall: Using a single central venous pressure as proof of fluid need ignores dynamic physiology. Even a responsive patient may face more harm than benefit from additional fluid.
Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
44.Why is norepinephrine the first-line vasopressor in septic shock?
Septic shock commonly includes pathologic vasodilation with inadequate arterial pressure despite resuscitation. Norepinephrine increases vascular tone and is recommended as the first-line vasopressor in the 2026 Surviving Sepsis Campaign. The decision to use it follows assessment of perfusion, fluid response and ongoing hypotension rather than an obligation to continue fluids indefinitely. Monitor pressure together with tissue perfusion and adverse effects; a better pressure reading alone does not prove that the entire shock state has resolved.
Apply it
A patient with septic shock remains hypotensive after appropriate initial fluid assessment, and further fluid is unlikely to improve flow. Start norepinephrine with appropriate monitoring while continuing source control, antimicrobial treatment and repeated evaluation of end-organ perfusion.
Common pitfall: Continuing fluid solely to postpone a vasopressor can worsen fluid burden. Conversely, restoring pressure should not end the search for persistent hypoperfusion or an uncontrolled source.
Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
45.How should serial lactate guide sepsis reassessment?
An elevated lactate can identify increased risk and help track the response to sepsis treatment, but it is not a direct measurement of intravascular volume. Production, adrenergic stimulation and impaired clearance can contribute to the result. The 2026 sepsis guidance supports serial assessment in context. Interpret the trajectory alongside blood pressure, capillary refill, urine output, mental status and treatment effects. Persistent elevation should trigger reassessment rather than automatic fluid administration until the number normalizes.
Apply it
After initial septic shock treatment, a patient's pressure and capillary refill improve but lactate remains elevated and pulmonary congestion worsens. Reassess the full clinical picture and possible contributors instead of using lactate alone to justify another fluid bolus.
Common pitfall: Equating every elevated lactate with volume depletion can cause unnecessary fluid loading. A falling lactate is encouraging but cannot substitute for assessment of other perfusion findings.
Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
46.When should procalcitonin influence antimicrobial decisions in sepsis?
Procalcitonin is an adjunctive biomarker, not a reliable gatekeeper for starting antimicrobials in a patient with suspected sepsis. The 2026 Surviving Sepsis Campaign advises against using it to decide whether to initiate treatment instead of clinical evaluation. In selected patients, procalcitonin together with clinical assessment can help guide discontinuation when source control is adequate and duration remains uncertain. Interpretation must account for the infection, clinical trajectory and competing reasons for an abnormal result.
Apply it
A patient has shock and a convincing infectious presentation, but the first procalcitonin result is low. Do not delay indicated antimicrobials because of that result. Revisit biomarker trends later only as part of a broader reassessment of treatment duration.
Common pitfall: Using a low early procalcitonin to exclude sepsis can delay needed therapy. Using a later value alone to stop treatment also ignores source control and clinical response.
Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
47.Why should pain assessment precede escalation of ICU sedation?
Pain can produce agitation, ventilator intolerance and physiologic stress, while deeper sedation may hide the behavior without treating its cause. PADIS supports routine pain assessment using patient self-report when possible and appropriate behavioral tools when self-report is unavailable. Treat identified pain and reassess before assuming that more sedation is the best response. Sedation goals still depend on the clinical situation, but analgesia and sedation are related interventions with different purposes and adverse-effect profiles.
Apply it
An intubated patient becomes agitated during turning and cannot speak. Use an appropriate behavioral pain assessment, review likely painful conditions and provide indicated analgesia before reflexively deepening sedation. Reassess both comfort and the reason for continued agitation.
Common pitfall: A quiet patient may still have pain, and an agitated patient may have several causes of distress. Sedation depth is not a valid substitute for pain assessment.
48.How do coordinated awakening and breathing assessments support ICU liberation?
The ICU Liberation bundle coordinates pain management, spontaneous awakening and breathing trials, sedation choice, delirium care, early mobility and family engagement. Pairing awakening and breathing assessments helps determine whether ongoing sedation or ventilatory support remains necessary when safety criteria are met. The bundle works through repeated coordinated reassessment, rather than a single extubation checklist. Successful performance in one component does not eliminate the need to assess airway protection, secretion management and the patient's broader clinical trajectory.
Apply it
A ventilated patient is improving but remains on unchanged sedation without daily reassessment. Coordinate eligible awakening and breathing assessments with nursing and respiratory therapy, then evaluate cognition, airway protection and the broader readiness for liberation from invasive support.
Common pitfall: Treating bundle elements as unrelated tasks can miss their combined value. A successful breathing trial alone does not guarantee safe extubation when airway protection remains inadequate.
Professional Caring & Ethical Practice20%
49.How should informed refusal be handled when a patient has decision-making capacity?
Respect for patient decision-making includes refusal of a recommended intervention after the patient understands the relevant information. Explore understanding, voluntariness, benefits, burdens and alternatives, and assess decision-making capacity for the particular choice. The AMA patient-rights statement supports accepting or refusing recommended care. A clinically unwise choice does not by itself establish incapacity. Continue offering appropriate care and document the discussion without using pressure, abandonment or family disagreement as a substitute for the patient's decision.
Apply it
An alert patient explains the likely consequences of refusing a procedure and gives a consistent reason based on personal goals. Clarify alternatives and remaining questions, document informed refusal and continue agreed treatment while addressing the family's concerns respectfully.
Common pitfall: Disagreement with the clinician does not establish incapacity. Family preference also does not automatically override a capable patient's informed decision about that patient's own treatment.
50.When should a patient's information be shared with family?
Patient rights include privacy and confidentiality as well as participation in decisions about care. When the patient can express preferences, clarify whom the patient authorizes to receive information and what may be discussed. Family involvement can improve support, but relationship alone should not be treated as unrestricted permission. Apply the relevant ethical and legal framework when the patient cannot decide or an exception is claimed. The practical starting point is a private conversation about the patient's wishes.
Apply it
A patient asks that a new diagnosis not be discussed with visiting relatives. Confirm the preference privately, document the communication plan and explain to the team how to include family support without disclosing information the patient has declined to share.
Common pitfall: Assuming that bedside presence permits unrestricted disclosure can breach trust. Confidentiality decisions require attention to patient authorization and applicable exceptions rather than a universal family-access rule.
51.How can a mutually acceptable care plan preserve patient control?
Caring practices include building trust, showing empathy and negotiating a plan that preserves the patient's participation and control. Start by identifying the patient's concern rather than assuming that refusal of one proposal means rejection of all care. Explain realistic options and seek an acceptable approach consistent with safety and goals. The ACNPC-AG competencies connect this relationship to comfort, emotional support and physiologic or psychological stability, making communication part of effective care rather than an optional courtesy.
Apply it
A patient declines scheduled nighttime care because repeated interruptions worsen distress and exhaustion. Discuss which assessments are essential, which can be clustered and how symptoms will trigger reassessment, creating a feasible plan that respects both safety and rest.
Common pitfall: Presenting every routine as nonnegotiable can undermine participation. Negotiation still requires honest explanation of essential monitoring and the consequences of changing the proposed plan.
52.How should clinicians support families during an acute deterioration?
A supportive crisis response combines clear information, acknowledgment of distress and practical opportunities for questions and participation. The ACNPC-AG caring competencies include crisis and stress management during changes in serious illness. Use plain descriptions of what is known, what is uncertain and what the team is doing next. Check understanding without promising an outcome that cannot be assured. Family engagement should remain consistent with the patient's wishes and should support, rather than displace, the patient's goals.
Apply it
During an unexpected ICU transfer, relatives receive conflicting explanations and become distressed. Arrange a coordinated update, acknowledge uncertainty, explain the immediate plan and identify a contact for further questions while confirming the patient's preferences for family involvement.
Common pitfall: False reassurance may briefly reduce distress but can damage trust when the course changes. Technical detail without checking understanding can leave families less informed despite a long conversation.
ACNPC-AG Exam Handbook — July 2026 · SCCM ICU Liberation Bundle
53.Why should important clinical discussions use competent language assistance?
Language assistance supports accurate communication, meaningful consent and equitable access to care. The National CLAS Standards call for competent language services and discourage use of untrained individuals or minors as interpreters. A family member may omit, alter or filter information, particularly during sensitive discussions. Speak directly to the patient, use manageable segments and confirm understanding. Language preference should be assessed individually rather than inferred from appearance, surname or the language used by accompanying relatives.
Apply it
A patient with limited English proficiency is considering an invasive procedure, and an adolescent relative offers to translate. Arrange a qualified interpreter, address the patient directly and confirm understanding of the procedure, alternatives and major risks before seeking a decision.
Common pitfall: Conversational fluency does not ensure competence to interpret clinical risks accurately. A relative's willingness to help should not replace appropriate language assistance for consequential discussions.
54.How can cultural preferences be incorporated without stereotyping?
Culturally responsive care starts with asking the individual about preferences, beliefs and decision-making needs rather than assigning expectations from a group identity. The CLAS Standards support respectful care responsive to cultural beliefs, language and communication needs. Explore what matters, identify a specific conflict and develop an acceptable plan when possible. Clinicians should also examine their own assumptions, because age, ethnicity, gender or religion alone does not predict how a particular patient wants care organized.
Apply it
A patient requests a spiritual practice before a nonemergency procedure. Ask what the practice involves and how the patient wants it accommodated, then coordinate a safe plan rather than assuming either that the request is impossible or that every similar patient wants it.
Common pitfall: Memorizing group traits can become stereotyping when individual preferences are never asked. Respectful accommodation also requires clarifying the actual request and any concrete clinical limitations.
55.How does teach-back reveal gaps in patient education?
Teach-back asks patients or caregivers to explain information in their own words or demonstrate a skill, allowing the clinician to assess how well the explanation worked. It is a check of communication rather than a test of intelligence or compliance. AHRQ recommends clear, manageable teaching followed by reassessment and explanation when needed. The response should reveal whether the learner can perform the actual task, such as describing warning signs or showing how a device will be used.
Apply it
After explaining a new inhaler, ask the patient to demonstrate its use as it will occur at home. If a step is missed, explain it differently and repeat the demonstration check before considering the teaching complete.
Common pitfall: Asking whether the patient understands invites an agreeable answer without demonstrating skill. Repeating identical wording may not correct the misunderstanding that teach-back has exposed.
56.What makes an interprofessional handoff actionable?
An actionable handoff transfers responsibility as well as information. The ACNPC-AG collaboration competencies emphasize shared planning, advanced communication and coordination across transitions. Communicate the current condition, active risks, pending results, required actions and who will act if a problem arises. Invite clarification so the receiving team can identify gaps before responsibility changes. A long summary is less useful when it omits the one unresolved issue that could alter treatment during the next shift.
Apply it
A patient transfers while a blood culture identification remains pending. State who will review the result, how it could change treatment and whom to contact for deterioration. Confirm that the receiving team accepts responsibility for the follow-up.
Common pitfall: Sending records without assigning follow-up can leave an important result unowned. Detail alone does not create a safe handoff if urgency and responsibility remain unclear.
57.Why is medication reconciliation a shared system process?
Medication reconciliation compares an accurate medication history with current orders and resolves discrepancies at transitions. The AHRQ MATCH toolkit emphasizes standardized processes, shared documentation and defined responsibilities. The goal is to distinguish intentional changes from omissions, duplications or unexplained differences. Copying a list forward does not establish accuracy. Patients, caregivers, pharmacy information and prior records may each contribute, but the team must identify who verifies the information and who resolves a clinically important discrepancy.
Apply it
At admission, the electronic list contains two anticoagulants and an outdated dose. Verify actual use through appropriate sources, determine which changes were intentional and reconcile the orders before the discrepancies are carried into the next care setting.
Common pitfall: Treating reconciliation as a completed checkbox can preserve dangerous errors. A shared record is useful only when discrepancies are investigated and responsibilities for resolution are clear.
58.How should patient needs determine the next level of care?
Systems thinking matches patient acuity, stability, frailty and resource needs to the capabilities of the receiving environment. The ACNPC-AG competencies specifically include determining when another level of care is needed and coordinating transitions. Consider monitoring frequency, treatment complexity, functional assistance, caregiver capacity and access to follow-up. A bed being available does not establish suitability. Safe transitions depend on whether the destination can actually deliver the required services and respond to foreseeable deterioration.
Apply it
A patient no longer needs an ICU intervention but still requires monitoring unavailable at the proposed destination. Compare care needs with the receiving unit's capabilities and arrange a suitable setting rather than transferring solely because a bed has opened.
Common pitfall: Administrative labels can conceal differences in actual services. Medical improvement does not automatically establish readiness for a setting with less monitoring or insufficient support.
59.How do absolute and relative risk reductions differ?
Absolute risk reduction is the difference between the comparison risk and intervention risk. Relative risk reduction expresses that difference as a proportion of the comparison risk. If complications fall from 10% to 6%, the absolute reduction is four percentage points and the relative reduction is 40%. Reporting both prevents an impressive proportional change from obscuring a small absolute benefit. Interpretation also requires attention to the population, outcome and observation period used to estimate those risks.
Apply it
A unit intervention reduces a defined complication from 12% to 9% over comparable periods. Calculate an absolute reduction of three percentage points and a relative reduction of 25%, then discuss whether the populations and outcome definitions were sufficiently comparable.
Common pitfall: Calling a three-percentage-point decline a 3% relative reduction confuses two measures. A risk change also does not prove causation when the comparison design permits other explanations.
CDC Principles of Epidemiology: Measures of Public Health Impact
60.How should guideline status and applicability influence practice change?
Clinical inquiry requires identifying whether a document is a final guideline, a focused update or a draft, then assessing its relevance to the patient and decision. A draft may inform discussion but should not be represented as a finalized recommendation. The ACNPC-AG competencies require critical appraisal and individualized guideline application. KDIGO described its 2026 AKI update as a draft being prepared for publication, so published 2012 recommendations anchor the AKI principles taught here.
Apply it
A committee proposes a new AKI protocol based on a public-review draft. Verify publication status, compare the proposed changes with finalized guidance and document the evidence and local rationale before presenting the policy as an established guideline requirement.
Common pitfall: A newer date does not establish final publication or stronger evidence. Conversely, older finalized guidance should be reassessed when a relevant final update becomes available.
KDIGO: Acute Kidney Injury and Acute Kidney Disease · ACNPC-AG Exam Handbook — July 2026
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Prioritize Cardiovascular, Multisystem and Respiratory decisions: distinguish unstable rhythms, choose appropriate ventilatory support and reassess shock using physiology.
- Practise calculations that change management: predicted-body-weight tidal volume, PaO2/FiO2 ratio, HHS osmolality, anion gap, AKI changes from baseline and absolute versus relative risk reduction.
- Use discriminating boundaries: disabling versus non-disabling stroke, conventional versus imaging-selected thrombolysis, ketone clearance versus hyperchloremic acidosis, and HIT probability versus antibody detection.
- Broaden disease review within subdivisions: include HHS, tumor lysis, febrile neutropenia, gastrointestinal hemorrhage, traumatic intracranial deterioration, necrotizing infection and fragility fractures.
- Allocate approximately one fifth of study time to professional competencies, including refusal, language assistance, teaching, transitions and evidence appraisal.
- Use the complete official outline to identify additional diagnoses, procedures and competencies beyond this selective guide.
A practical preparation plan
1. Map the full outline
Compare the official patient care problems, procedure list and validated competencies with your graduate preparation. Mark gaps by clinical subdivision and professional competency, preserving the published 80%/20% emphasis.
2. Build decision pairs
For each concept, state the finding that changes the action: pulse and instability, monomorphic versus polymorphic rhythm, respiratory acidosis, disabling function, potassium safety or persistent ketonemia.
3. Apply and calculate
Work the mini-cases without viewing the answer. Calculate changes from baseline, weight-based ventilator targets, oxygenation ratios, osmolality and clinical probability scores explicitly, then explain how each result affects the decision.
4. Review every distractor
Complete the 20 independent questions. For each missed item, explain why every alternative is less appropriate and identify the clinical detail that would make another option reasonable.
5. Rehearse professional decisions
Practise a brief informed-refusal conversation, an interpreter-supported discussion, a teach-back request and a handoff assigning responsibility for pending results. Evaluate each against the relevant professional competency.
6. Use spaced recall and current references
Revisit the flashcards at increasing intervals. Check the official handbook for examination scope and the relevant finalized clinical guidance for treatment details, noting publication status when considering newer recommendations.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ACNPC-AG Certification
- ACNPC-AG Exam Handbook — July 2026
- 2025 AHA Guidelines: Adult Advanced Life Support
- 2022 AHA/ACC/HFSA Heart Failure Guideline Slide Set
- New ACC, AHA, HFSA Guideline Updates Recommendations for Managing HF
- 2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2
- ATS/ESICM/SCCM Guideline: Mechanical Ventilation in Adult ARDS
- Official ERS/ATS Guidelines: Noninvasive Ventilation for Acute Respiratory Failure
- Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report — 2024
- ASH: Diagnosis and Management of Heparin-Induced Thrombocytopenia
- ACG Guideline Highlights: Acute Pancreatitis — 2024
- KDIGO: Acute Kidney Injury and Acute Kidney Disease
- KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
- AHA/ASA: Top Take-Home Messages for the Emergency Physician — 2026 Stroke Guideline
- SCCM PADIS Guidelines — 2018
- A Focused Update to SCCM PADIS Guidelines — 2025
- SCCM ICU Liberation Bundle
- Surviving Sepsis Campaign: Adult Sepsis and Septic Shock Guidelines — 2026
- IDSA Guidelines: Skin and Soft Tissue Infections
- AAOS: Fragility Fractures — Frequently Asked Questions
- AHRQ: Tool — Teach-Back
- HHS: National CLAS Standards
- AMA Code of Medical Ethics: Patient Rights
- AHRQ MATCH Toolkit: Introduction
- CDC Principles of Epidemiology: Measures of Public Health Impact
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease — Slide Set
- watermark-ash_vte_hit_pocketguide.pdf
- SCCM/IDSA Guidelines for Evaluating New Fever in Adult Patients in the ICU
- clin-management-tumor-lysis-web-algorithm.pdf
- CAG-CPG-Nonvariceal-UGIB-Annals-Dec2019.pdf
- 2026-guideline-for-the-early-management-of-patients-with-acute-ischemic-stroke-a-guideline-from.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.